UNSPSC 51192011: Isobromindione

This classification denotes a uricosuric agent with the molecular formula C15H9BrO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J1J87P409K, chemically known as 1,3-indandione, 5-bromo-2-phenyl- but generally known as isobromindione, which bears US NIH Compound Identifier 68953. European Medicines Agency schedules Isobromindione in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08311MIG.

UNSPSC 51192011 Isobromindione is a Commodity code that appears in state and local procurement activity with minimal relevance to its nominal chemical designation. The recent opportunities tagged under this code do not involve isobromindione procurement; instead, they reflect athletic training services, first-aid and medical supplies, and pharmacy benefit program inquiry. State and local governments do not appear to be actively buying isobromindione through public procurement channels visible in recent solicitation activity. The code shows no clear connection between its chemical product name and the work actually being solicited under it.

The City of Tucson issued an RFP on May 13, 2026 (due June 9, 2026) for comprehensive athletic training services to the Fire and Police Departments, requiring NATA BOC and NSCA TSAC-F certified trainers with three years of experience. The City of Tampa issued an ITB on April 24, 2026 (due April 9, 2025—an apparent date error in the source) for medical aid supplies including bandages, antiseptic sprays, and first-aid kits for the Fire Rescue Department, with a $100,000 department budget and set-asides for small local and minority-owned businesses. The Texas Health and Human Services Commission posted an RFI on April 3, 2026 seeking vendor capabilities for a direct-to-manufacturer prescription program. These three opportunities span Arizona, Florida, and Texas, but none address the chemical compound named in the code, and the code appears to carry a classification mismatch rather than reflect active demand for isobromindione in state and local procurement.